Oriol Mirallas Publishes Review on Targeting Regulatory T Cells for Cancer Immunotherapy
Oriol Mirallas and colleagues have published a review in the Annals of Oncology regarding the targeting of regulatory T cells for cancer immunotherapy. The paper explores the biological complexities and potential therapeutic strategies for this approach.
Why it matters
Advancements in immunotherapy research are critical for developing more effective, targeted treatments for various types of cancer.
Oriol Mirallas , Clinical Fellow in the Investigational Cancer Therapeutics (ICT) Department at the University of Texas MD Anderson Cancer Center, shared a post on LinkedIn :
“Pleased to share that our review, ‘Targeting regulatory T cells for cancer immunotherapy : promises and pitfalls,’ is now available in the August issue of Annals of Oncology .
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in